4-Hydroxy-2,2,6,6-tetramethylpiperidine
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
2403-88-5CC1(C)CC(O)CC(C)(C)N1VDVUCLWJZJHFAV-UHFFFAOYSA-NRN given refers to parent cpd
2403-88-5DTXSID3029655CHEMBL117625Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 2.5% (5 of 201) of reports.
Danger
H302 (65.7%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P261, P264, P264+P265, P270, P272, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P333+P317, P362+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 201 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
Status: Active Update: 22-07-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/14709
2,2,6,6-Tetramethyl-4-piperidinol: Does not have an individual approval but may be used under an appropriate group standard
Acute Tox. 4 (65.7%)
Acute toxicity (Oral) - Category 4
Verwenden2,2,6,6-tetramethyl-4-piperidinol has been used to study the irradiation of Camptothecin (CPT) in aerated dimethylsulfoxide (DMSO) solution that leads to formation of singlet oxygen.
Wird geladen…